Oral treatment with Cu(II)(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosis
口服 Cu(II)(atsm) 可增加体内突变型 SOD1，但保护运动神经元并改善肌萎缩侧索硬化症转基因小鼠模型的表型
期刊:Journal of Neuroscience
影响因子:4.4
doi:10.1523/JNEUROSCI.4196-13.2014
Blaine R Roberts, Nastasia K H Lim, Erin J McAllum, Paul S Donnelly, Dominic J Hare, Philip A Doble, Bradley J Turner, Katherine A Price, Sin Chun Lim, Brett M Paterson, James L Hickey, Timothy W Rhoads, Jared R Williams, Katja M Kanninen, Lin W Hung, Jeffrey R Liddell, Alexandra Grubman, Jean-Franc
